| 1 | BT474 modified to resistant clone BT-HRc3, Infected with lentiviral GDF15 shRNA (shGDF) | 1 | 1 |
| 2 | BT474 modified to resistant clone BT474/TR | 20 | 1 |
| 3 | BT474 modified to resistant clone BT474/TR, Treadted with 2-DEOXY-D-GLUCOSE (Glycolysis inhibitor) | 4 | 1 |
| 4 | BT474 modified to resistant clone BT474/TR, Treadted withOXAMATE (Glycolysis inhibitor) | 4 | 1 |
| 5 | Make cell line resistant to trastuzumab | 12 | 1 |
| 6 | NSC23766 (Inhibitor of RAC1) | 1 | 1 |
| 7 | SKBR3 modified to resistant SKBR3/mAbHER2 | 1 | 1 |
| 8 | SKBR3 modified to resistant SKBR3/mAbHER3 | 1 | 1 |
| 9 | SKBR3 modified to resistant SKBR3/mAbHER4 | 1 | 1 |
| 10 | SKBR3 modified to resistant SKBR3/mAbHER5 | 1 | 1 |
| 11 | SKBR3 modified to resistant SKBR3/mAbHER6 | 1 | 1 |
| 12 | SKBR3 modified to resistant SKBR3/mAbHER7 | 1 | 1 |
| 13 | Trasfected with GRB7 siRNA | 15 | 3 |
| 14 | Trasfected with GRB7 siRNA with Trasfected with HER2 siRNA | 3 | 3 |
| 15 | Trasfected with GSDM1 siRNA | 12 | 3 |
| 16 | Trasfected with HER2 siRNA | 42 | 3 |
| 17 | Trasfected with PERLD1 siRNA | 12 | 3 |
| 18 | Trasfected with PPP1R1B siRNA | 15 | 3 |
| 19 | Trasfected with PPP1R1B siRNA with Trasfected with HER2 siRNA | 3 | 3 |
| 20 | Trasfected with PSMD3 siRNA | 15 | 3 |
| 21 | Trasfected with PSMD3 siRNA with Trasfected with HER2 siRNA | 3 | 3 |
| 22 | Trasfected with SCRAMBLE siRNA | 24 | 3 |
| 23 | Trasfected with STARD3 siRNA | 6 | 3 |
| 24 | Trasfected with STARD3 siRNA with Trasfected with HER2 siRNA | 3 | 3 |
| 25 | Trasfected with THRA siRNA | 15 | 3 |
| 26 | Trasfected with THRA siRNA with Trasfected with HER2 siRNA | 3 | 3 |
| 27 | Trasfected with ZPBP2 siRNA | 15 | 3 |
| 28 | Trasfected with ZPBP2 siRNA with Trasfected with HER2 siRNA | 3 | 3 |
| 29 | Trastuzumab resistant BT474 (BT474R) | 8 | 1 |
| 30 | Trastuzumab resistant SKBR3 (SKBR-3R) | 8 | 1 |
| 31 | Treated with Laminin rich extracellular matrix culture (IrECM) | 16 | 1 |
| 32 | 17-AAG (Down regulate ERBB2) | 10 | 2 |
| 33 | AU565 Culture in 2D MONOLAYER | 6 | 1 |
| 34 | AU565 Culture in 3D IrECM | 6 | 1 |
| 35 | Anti-Estrogen inhibitor (Fulvestrant) , Treated MCF7Ca with Letrozole for 56 week | 1 | 1 |
| 36 | Anti-Estrogen inhibitor (Fulvestrant)r , Treated MCF7Ca with Letrozole for 56 week | 1 | 1 |
| 37 | Anti-Estrogen inhibitor (Tamoxifen ) , Treated MCF7Ca with Letrozole for 56 week | 2 | 1 |
| 38 | Aromatase inhibitor (Anastrozole ), Treated MCF7Ca with letrozole for 56 week | 2 | 1 |
| 39 | Aromatase inhibitor (Exemestane ), Treated MCF7Ca with letrozole for 56 week | 2 | 1 |
| 40 | BT474 Transfected with p110a subunit of PI3K (BT474H1047R) | 8 | 1 |
| 41 | BT474 modifie to resitanr clone BT474-TR, Inhibition of Akt and S6K phosphorylation | 2 | 1 |
| 42 | BT474 modified to clone BT474 SC | 9 | 1 |
| 43 | BT474 modified to clone BT474-c3 | 3 | 1 |
| 44 | BT474 modified to resistant BT474 (HR2), Trasfected by RshRNA to knockdown IGF-IR | 8 | 2 |
| 45 | BT474 modified to resistant clone BT-HRc3, Infected with lentiviral Control sh RNA (shC) | 1 | 1 |
| 46 | BT474 modified to resistant clone BT/HerR | 12 | 1 |
| 47 | BT474 modified to resistant clone BT474 /TR | 3 | 1 |
| 48 | BT474 modified to resistant clone BT474 HR5 | 5 | 1 |
| 49 | BT474 modified to resistant clone BT474 HR6 | 5 | 1 |
| 50 | BT474 modified to resistant clone BT474- HR5 | 4 | 1 |
| 51 | BT474 modified to resistant clone BT474- HR6 | 4 | 1 |
| 52 | BT474 modified to resistant clone BT474-HR20 | 9 | 1 |
| 53 | BT474 modified to resistant clone BT474-HRc1 | 9 | 1 |
| 54 | BT474 modified to resistant clone BTres1 | 20 | 1 |
| 55 | BT474 modified to resistant clone BTres2 | 6 | 1 |
| 56 | BT474 varient | 5 | 1 |
| 57 | BT549 Culture in 2D MONOLAYER | 6 | 1 |
| 58 | BT549 Culture in 3D IrECM | 6 | 1 |
| 59 | Cell line modified to MCF-7/HER2 | 11 | 1 |
| 60 | Cell treated with Glycolysis inhibitor | 20 | 4 |
| 61 | Cell treated with Glycolysis inhibitor, BT474 modified to resistant clone BT474/TR | 4 | 1 |
| 62 | Cell treated with lactate dehydrogenase inhibitor | 20 | 4 |
| 63 | Cell treated with lactate dehydrogenase inhibitor , BT474 modified to resistant clone BT474/TR | 4 | 1 |
| 64 | Cyclin D kinase 4/6 inhibitor (PD 0332991) | 18 | 3 |
| 65 | Ectopic expression of CYCLIN E | 2 | 1 |
| 66 | Empty vector | 20 | 3 |
| 67 | Empty vector tranfected in MCF-7/HER-2/EV | 2 | 1 |
| 68 | Empty vector tranfected in SKBR3-EV | 15 | 1 |
| 69 | Estrogen receptor inhibition, Cell line modified to MCF-7/HER2 | 5 | 1 |
| 70 | Exogenous stimulation by BTC | 1 | 1 |
| 71 | Exogenous stimulation by EGF | 1 | 1 |
| 72 | Exogenous stimulation by HRG | 1 | 1 |
| 73 | Expression of cleaved caspase 3 | 1 | 1 |
| 74 | Expression of scrambled SIRNA | 1 | 1 |
| 75 | Expression of scrambled SIRNA, Make cell line resistant to trastuzumab | 1 | 1 |
| 76 | HCC1569 Culture in 2D MONOLAYER | 6 | 1 |
| 77 | HCC1569 Culture in 3D IrECM | 6 | 1 |
| 78 | HCC1954 treated with LY294002 ( PI3K inhibitor) | 1 | 1 |
| 79 | HER2 silencing in BT474 | 1 | 1 |
| 80 | HER2 silencing in JIMT4 | 1 | 1 |
| 81 | HER2 silencing in KPL4 | 1 | 1 |
| 82 | HER2 silencing in MCF7 | 1 | 1 |
| 83 | HER2 silencing in SKBR3 | 1 | 1 |
| 84 | High express cyclinE, Make cell line resistant to trastuzumab | 2 | 1 |
| 85 | High express p27 | 3 | 1 |
| 86 | High express p27, Make cell line resistant to trastuzumab | 2 | 1 |
| 87 | IGF-IR TRANSFECTED, SKBR3 modified to clone SKBR3/IGF-IR | 13 | 1 |
| 88 | Infected with lentiviral Control sh RNA (shC) | 5 | 3 |
| 89 | Infected with lentiviral GDF15 shRNA (shGDF) | 5 | 3 |
| 90 | Inhibition of ADAM17 | 12 | 1 |
| 91 | Inhibition of Akt and S6K phosphorylation | 10 | 8 |
| 92 | Inhibition of Topo IIα | 4 | 1 |
| 93 | Inhibition of all panHER receptors | 6 | 1 |
| 94 | Inhibitor of IGF-IR tyrosine kinase | 12 | 1 |
| 95 | Knockdown ATG12 | 3 | 1 |
| 96 | Knockdown of CYCLIN E by specific Si RNA | 2 | 1 |
| 97 | Knockdown of CYCLIN E by specific Si RNA, Make cell line resistant to trastuzumab | 1 | 1 |
| 98 | MCF-7 exposed to rHuEPO, MCF7 modified to clone MCF7-HER-18 | 7 | 1 |
| 99 | MCF10A modified to MCF10A. HER2 | 8 | 1 |
| 100 | MCF7 modified to clone MCF7-HER-18 | 34 | 1 |
| 101 | MCF7 modified to clone MCF7/HER2 | 3 | 1 |
| 102 | MCF7 transfected by erbB-2 (MCF7/erbB2) | 4 | 1 |
| 103 | MDA-MB-453 exposed to rHuEPO | 2 | 1 |
| 104 | MDA-MB-453 modified to resistant cell line (MDA-MB-453R) | 8 | 1 |
| 105 | MOCK TRANSFECTED, SKBR3 modified to clone SKBR3/neo | 13 | 1 |
| 106 | MOCK TRANSFECTED, SKBR3 modified to clone SKBR3/neo | 2 | 1 |
| 107 | MODIFICATION OF CELL LINE | 1 | 1 |
| 108 | Make cell line resistant to trastuzumab | 16 | 1 |
| 109 | Met receptor knockdown | 4 | 2 |
| 110 | NF-kB downregulation | 2 | 1 |
| 111 | No expression of cleaved caspase 3 | 3 | 1 |
| 112 | None | 882 | 45 |
| 113 | Over express TIMP-1 | 1 | 1 |
| 114 | Over express TIMP-1, SKBR3 modified to clone SKBR3 C2 CLONE | 1 | 1 |
| 115 | Over express TIMP-1, SKBR3 modified to clone SKBR3 C3 CLONE | 1 | 1 |
| 116 | Over express TIMP-1, SKBR3 modified to clone SKBR3 C4 CLONE | 1 | 1 |
| 117 | Over express TIMP-1, SKBR3 modified to clone SKBR3 C5 CLONE | 1 | 1 |
| 118 | Over express TIMP-1, SKBR3 modified to clone SKBR3 CI CLONE | 1 | 1 |
| 119 | PCDGF/GP88 Cdna stably transfected in SKBR3 (SKBR3-GP88) | 3 | 1 |
| 120 | PI3K INHIBITOR | 32 | 1 |
| 121 | PI3K INHIBITOR, Trasfected by MYR-AKT1, SKBR3 modified to clone SKBR3/AA28 | 1 | 1 |
| 122 | PI3K INHIBITOR,Trasfected by MYR-AKT1, SKBR3 modified to clone SKBR3/AA28 | 1 | 1 |
| 123 | PIK3CA mt | 12 | 4 |
| 124 | PIK3CA wt | 12 | 4 |
| 125 | Parental SKBR3 | 10 | 1 |
| 126 | Parental SKBR3, transfected with 100 ng of pCMV-FLAG-p27kip1 | 3 | 1 |
| 127 | Parental SKBR3, transfected with 25 ng of pCMV-FLAG-p27kip1 | 3 | 1 |
| 128 | Parental SKBR3, transfected with vector control | 3 | 1 |
| 129 | Pretreated with GDF15 for 48 HRS | 7 | 2 |
| 130 | SK-HRc3 (SKBR3 Resistant cell line), Infected with lentiviral Control sh RNA (shC) | 1 | 1 |
| 131 | SK-HRc3 (SKBR3 Resistant cell line), Infected with lentiviral GDF15 shRNA (shGDF) | 1 | 1 |
| 132 | SKBR3 Culture in 2D MONOLAYER | 6 | 1 |
| 133 | SKBR3 Culture in 3D IrECM | 6 | 1 |
| 134 | SKBR3 Resistant cell line (SKBR3- HR), Tranfected with HSP27 SiRNA | 4 | 1 |
| 135 | SKBR3 Resistant cell line (SKBR3- HR), Tranfected with control NS SiRNA | 4 | 1 |
| 136 | SKBR3 exposed to rHuEPO | 4 | 1 |
| 137 | SKBR3 modified to resistant SKBR3 (POOL2), Trasfected by B3shRNA to knockdown erbB3 | 2 | 2 |
| 138 | SKBR3 modified to resistant SKBR3 (POOL2), Trasfected by B3shRNA to knockdown erbB4 | 2 | 2 |
| 139 | SKBR3 modified to resistant SKBR3 (POOL2), Trasfected by B3shRNA to knockdown erbB5 | 2 | 2 |
| 140 | SKBR3 modified to resistant SKBR3 (POOL2), Trasfected by B3shRNA to knockdown erbB6 | 2 | 2 |
| 141 | SKBR3 modified to resistant cell line (SKBR3R) | 8 | 1 |
| 142 | SKBR3 modified to resistant clone SKBR3-HRp2 | 19 | 1 |
| 143 | SKBR3 modified to resistant clone SKBR3-HRp3 | 19 | 1 |
| 144 | SKBR3 modified to resistant clone SKBR3-R, Transfected with dominant negative SPRY2Y55F | 2 | 1 |
| 145 | SKBR3 modified to resistant clone SKBR3-R, Transfected with dominant negative SPRY2Y55F | 1 | 1 |
| 146 | SKBR3 modified to resistant clone SKBR3-pool2 | 9 | 1 |
| 147 | SKBR3 modified to resistant clone SKBR3/R | 5 | 1 |
| 148 | SKBR3 modified to resistant clone SKBR3/R, Trasfected with EPOR shRNA | 1 | 1 |
| 149 | SKBR3 modified to resistant clone SKBR3/R, Trasfected with srambled shRNA | 1 | 1 |
| 150 | Stable GDF15 overexpresed in BT474 (GDFc2)Clone | 6 | 1 |
| 151 | Stable GDF15 overexpresed in BT474 (GDFc3)Clone | 6 | 1 |
| 152 | Stable GDF15 overexpresed in SKBR3 (GDFc3) Clone | 1 | 1 |
| 153 | Stable GDF15 overexpresed in SKBR3 (GDFc4) Clone | 1 | 1 |
| 154 | Stable GDF15 overexpresed in SKBR3 (GDFc5) Clone | 1 | 1 |
| 155 | T47D trasfected by HER2 | 3 | 1 |
| 156 | T47D trasfected by P95her2 | 3 | 1 |
| 157 | TRANFECTED BY MYR-AKT1 , BT474 modified to clone BT474/AA9 | 1 | 1 |
| 158 | TRANFECTED BY MYR-AKT1, BT474 modified to clone BT474/AA9 | 1 | 1 |
| 159 | TRANFECTED BY MYR-AKT1, SKBR3 modified to clone SKBR3/AA28 | 6 | 1 |
| 160 | TRANFECTED BY dominant negative akt1, BT474 modified to clone BT474/DN5 | 2 | 1 |
| 161 | TRANFECTED BY dominant negative akt1, SKBR3 modified to clone SKBR3/DN9 | 5 | 1 |
| 162 | TRANFECTED BY pUSEamp with , BT474 modified to clone BT474/V | 2 | 1 |
| 163 | TRANFECTED BY pUSEamp with , SKBR3 modified to clone SKBR3/V33 | 5 | 1 |
| 164 | TRANSDUCED PTEN ANTISENCE | 1 | 1 |
| 165 | TRANSFECTED BY pBabe | 16 | 1 |
| 166 | TRANSFECTED BY pBabe-FoxM1 | 8 | 1 |
| 167 | Tamoxifen Resistant cell line | 6 | 1 |
| 168 | Transdused by CA-EphA2 | 4 | 2 |
| 169 | Transdused by CA-EphA2, MCF10A modified to MCF10A. HER2 | 2 | 1 |
| 170 | Transdused by KD-EPHA2 to knockdown | 2 | 1 |
| 171 | Transdused by KD-EPHA2 to knockdown, MCF10A modified to MCF10A. HER2 | 2 | 1 |
| 172 | Transdused by antisence PTEN | 7 | 2 |
| 173 | Transdused by mismatched oligonucleotide | 5 | 2 |
| 174 | Transfected and overexpress with Alk5TD | 2 | 1 |
| 175 | Transfected with HER2 and overexpressed | 12 | 6 |
| 176 | Transfected with HSF1 SiRNA1 | 2 | 2 |
| 177 | Transfected with HSF1 SiRNA2 | 2 | 2 |
| 178 | Transfected with P3xflag PTEN mut, BT474 modified to resistant clone R-BT474 | 6 | 1 |
| 179 | Transfected with P3xflagvector alone, BT474 modified to resistant clone R-BT474 | 6 | 1 |
| 180 | Transfected with PCDNA3.0/TDARPP.A vector | 4 | 1 |
| 181 | Transfected with PCDNA3.0/TDARPP.A with DARPP-32 D vector | 6 | 1 |
| 182 | Transfected with SKBR3 PLENTI7.3 | 2 | 1 |
| 183 | Transfected with SKBR3-IGF-IR to overexpress IGF-IR | 20 | 1 |
| 184 | Transfected with SKBR3-IGF-IR to overexpress IGF-IR with Trasfected with nonspecific siRNA | 1 | 1 |
| 185 | Transfected with SKBR3-IGF-IR to overexpress IGF-IR with Trasfected with specific Tiam 1 siRNA | 1 | 1 |
| 186 | Transfected with SPRY2 | 4 | 2 |
| 187 | Transfected with SPRY2, SKBR3 modified to resistant clone SKBR3-R | 2 | 1 |
| 188 | Transfected with anti-miR-200 | 1 | 1 |
| 189 | Transfected with dominant negative SPRY2Y55F | 4 | 2 |
| 190 | Transfected with empty PCDNA3.0/NEO1 vector | 2 | 1 |
| 191 | Transfected with empty PCDNA3.0/NEO2 vector | 2 | 1 |
| 192 | Transfected with empty vector | 4 | 2 |
| 193 | Transfected with empty vector, SKBR3 modified to resistant clone SKBR3-R | 2 | 1 |
| 194 | Transfected with miR-21 MIMICS | 28 | 3 |
| 195 | Transfected with miR-21 mimics | 18 | 1 |
| 196 | Transfected with miR-21 mimics with p3XFLAG | 12 | 1 |
| 197 | Transfected with miR-21 mimics with p3XFLAG-PTEN-MUT | 6 | 1 |
| 198 | Transfected with miR-21ASO, BT474 modified to resistant clone R-BT474 | 26 | 3 |
| 199 | Transfected with miR-21ASO, MDA-MB-453 modified to resistant clone R-MDA-MB-453 | 2 | 1 |
| 200 | Transfected with miR-21ASO, SKBR3modified to resistant clone R-SKBR3 | 2 | 1 |
| 201 | Transfected with non specific Lin4 MIMICS | 28 | 3 |
| 202 | Transfected with non specific Lin4ASO, BT474 modified to resistant clone R-BT474 | 26 | 3 |
| 203 | Transfected with non specific Lin4ASO, MDA-MB-453 modified to resistant clone R-MDA-MB-453 | 2 | 1 |
| 204 | Transfected with non specific Lin4ASO, SKBR3modified to resistant clone R-SKBR3 | 2 | 1 |
| 205 | Transfected with non specific mock | 70 | 3 |
| 206 | Transfected with non specific mock, BT474 modified to resistant clone R-BT474 | 32 | 3 |
| 207 | Transfected with non specific mock, MDA-MB-453 modified to resistant clone R-MDA-MB-453 | 2 | 1 |
| 208 | Transfected with non specific mock, SKBR3 modified to resistant clone R-SKBR3 | 2 | 1 |
| 209 | Transfected with nonspecific siCtrl | 2 | 1 |
| 210 | Transfected with siSLC to knock down SLC25A43 | 2 | 1 |
| 211 | Transfeted with IGF1R si-RNA | 8 | 2 |
| 212 | Transfeted with empty vector and overexpresed | 4 | 1 |
| 213 | Transfeted with scrambled siRNA | 11 | 2 |
| 214 | Transfeted with t-DARP siRNA | 3 | 1 |
| 215 | Transfeted with t-DARPP-1 and overexpresed | 8 | 1 |
| 216 | Transfeted with t-DARPPsiRNA | 3 | 1 |
| 217 | Trasfected BY specific SiRNA- FoxM1 | 1 | 1 |
| 218 | Trasfected by EMPTY VECTOR Pcdna3, MCF7 modified to HER-2 overexpress clone MCF7-HER2 | 2 | 1 |
| 219 | Trasfected by FOXO1A | 8 | 3 |
| 220 | Trasfected by FOXO1A, BT474 modified to clone BT474/AA9 | 2 | 1 |
| 221 | Trasfected by FOXO1A, MCF7 modified to HER-2 overexpress clone MCF7-HER2 | 2 | 1 |
| 222 | Trasfected by FOXO1A, SKBR3 modified to clone SKBR3/AA28 | 2 | 1 |
| 223 | Trasfected by P-1257 peptide | 6 | 3 |
| 224 | Trasfected by P-SCR peptide | 6 | 3 |
| 225 | Trasfected by empty vecto Pcdna3, SKBR3 modified to clone SKBR3/AA28 | 1 | 1 |
| 226 | Trasfected by empty vector Pcdna3 | 5 | 2 |
| 227 | Trasfected by empty vector Pcdna3, BT474 modified to clone BT474/AA9 | 2 | 1 |
| 228 | Trasfected by empty vector Pcdna3, SKBR3 modified to clone SKBR3/AA28 | 1 | 1 |
| 229 | Trasfected by non specific SiRNA | 16 | 2 |
| 230 | Trasfected by non specific SiRNA | 11 | 2 |
| 231 | Trasfected by non specific SiRNA, MDA-MB-453 modified to resistant cell line (MDA-MB-453R) | 2 | 1 |
| 232 | Trasfected by non specific SiRNA, SKBR3 modified to resistant cell line (SKBR3R) | 2 | 1 |
| 233 | Trasfected by pBabe | 30 | 3 |
| 234 | Trasfected by pBabe-FoxM1 | 15 | 3 |
| 235 | Trasfected by specific SiRNA- FoxM1 | 13 | 2 |
| 236 | Trasfected by specific SiRNA- FoxM1 | 9 | 2 |
| 237 | Trasfected by specific SiRNA- FoxM1, MDA-MB-453 modified to resistant cell line (MDA-MB-453R) | 1 | 1 |
| 238 | Trasfected by specific SiRNA- FoxM1, SKBR3 modified to resistant cell line (SKBR3R) | 2 | 1 |
| 239 | Trasfected by specific SiRNA- FoxM1, SKBR3 modified to resistant cell line (SKBR3R) | 1 | 1 |
| 240 | Trasfected by specific- FoxM1 CONTROL | 1 | 1 |
| 241 | Trasfected by specific- FoxM1, MDA-MB-453 modified to resistant cell line (MDA-MB-453R) | 1 | 1 |
| 242 | Trasfected with Control shRNA | 3 | 1 |
| 243 | Trasfected with Ctrl siRNA | 12 | 1 |
| 244 | Trasfected with Ctrl siRNA, BT474 modified to resistant clone BTres1 | 6 | 1 |
| 245 | Trasfected with EPOR shRNA | 2 | 1 |
| 246 | Trasfected with GSDM1 siRNA with Trasfected with HER2 siRNA | 3 | 3 |
| 247 | Trasfected with HER2 siRNA | 48 | 3 |
| 248 | Trasfected with PERLD1 siRNA with Trasfected with HER2 siRNA | 3 | 3 |
| 249 | Trasfected with SIRNA against IQGAP(SIIQ12) | 10 | 1 |
| 250 | Trasfected with SIRNA against IQGAP(SIIQ12) and resistant SIRNA | 2 | 1 |
| 251 | Trasfected with SIRNA against IQGAP(SIIQ12) and vector | 2 | 1 |
| 252 | Trasfected with SIRNA against IQGAP(SIIQ12) and vector | 1 | 1 |
| 253 | Trasfected with SIRNA against IQGAP(SIIQ12), SKBR3 modified to resistant clone SKBR3-TR | 2 | 1 |
| 254 | Trasfected with SIRNA against IQGAP(SIIQ14), SKBR3 modified to resistant clone SKBR3-TR | 2 | 1 |
| 255 | Trasfected with SIRNA against RENILLA LUSIFERASE(SIREN) | 10 | 1 |
| 256 | Trasfected with SIRNA against RENILLA LUSIFERASE(SIREN) and vector | 6 | 1 |
| 257 | Trasfected with SIRNA against RENILLA LUSIFERASE(SIREN) and vector, SKBR3 modified to resistant clone SKBR3-TR | 1 | 1 |
| 258 | Trasfected with SIRNA against RENILLA LUSIFERASE(SIREN) and vector,SKBR3 modified to resistant clone SKBR3-TR | 1 | 1 |
| 259 | Trasfected with SIRNAs against IQGAP AND P27(SIIQ12 AND SIP27) | 4 | 1 |
| 260 | Trasfected with SKBR3-PTEN-sh13 to knock down PTEN | 20 | 1 |
| 261 | Trasfected with SKBR3-PTEN-sh13 to knock down PTEN with Trasfected with nonspecific siRNA | 1 | 1 |
| 262 | Trasfected with SKBR3-PTEN-sh13 to knock down PTEN with Trasfected with specific Tiam 1 siRNA | 1 | 1 |
| 263 | Trasfected with SKBR3-PTEN-sh19 to knock down PTEN | 18 | 1 |
| 264 | Trasfected with SKBR3-Pmko.1 emptyvector | 2 | 1 |
| 265 | Trasfected with STARD3 siRNA | 15 | 3 |
| 266 | Trasfected with antisense PTEN, BT474 modified to clone BT474.m1 | 32 | 1 |
| 267 | Trasfected with antisense PTEN, BT474 modified to clone BT474.m1 | 3 | 1 |
| 268 | Trasfected with non specific oligonucleoted, BT474 modified to clone BT474.m1 | 14 | 1 |
| 269 | Trasfected with non specific shRNA | 2 | 1 |
| 270 | Trasfected with specific CTRL SIRNA | 1 | 1 |
| 271 | Trasfected with specific CTRL SIRNA, Transfected with Alk5TD | 1 | 1 |
| 272 | Trasfected with specific ERBB3 SIRNA | 2 | 1 |
| 273 | Trasfected with specific ERBB3 SIRNA , Transfected with Alk5TD | 1 | 1 |
| 274 | Trasfected with specific MUC1 shRNA | 4 | 1 |
| 275 | Trasfected with specific MUC1 siRNA, BT474 modified to resistant clone BTres1 | 6 | 1 |
| 276 | Trasfected with specific TACE SIRNA | 1 | 1 |
| 277 | Trasfected with specific TACE SIRNA, Transfected with Alk5TD | 1 | 1 |
| 278 | Trasfected with srambled shRNA | 1 | 1 |
| 279 | Trastuzuamb Resistant SKBR3 (pool1) | 19 | 1 |
| 280 | Trastuzuamb Resistant SKBR3 (pool1), a-IR3 blocks the receptor-binding domain of IGF-IR | 6 | 1 |
| 281 | Trastuzuamb Resistant SKBR3 (pool1), transfected with 100 ng of pCMV-FLAG-p27kip1 | 3 | 1 |
| 282 | Trastuzuamb Resistant SKBR3 (pool1), transfected with 25 ng of pCMV-FLAG-p27kip1 | 3 | 1 |
| 283 | Trastuzuamb Resistant SKBR3 (pool1), transfected with vector control | 3 | 1 |
| 284 | Trastuzuamb Resistant SKBR3 (pool2) | 28 | 1 |
| 285 | Trastuzuamb Resistant SKBR3 (pool2), Inhibitor of IGF-IR tyrosine kinase | 6 | 1 |
| 286 | Trastuzuamb Resistant SKBR3 (pool2), a-IR3 blocks the receptor-binding domain of IGF-IR | 6 | 1 |
| 287 | Trastuzuamb Resistant SKBR3 (pool2), transfected with 100 ng of pCMV-FLAG-p27kip1 | 3 | 1 |
| 288 | Trastuzuamb Resistant SKBR3 (pool2), transfected with 25 ng of pCMV-FLAG-p27kip1 | 3 | 1 |
| 289 | Trastuzuamb Resistant SKBR3 (pool2), transfected with vector control | 3 | 1 |
| 290 | Trastuzumab resistant refractory pool 2 BT474 (BT-HRp3) | 3 | 1 |
| 291 | Trastuzumab resistant refractory pool 2 SKBR3 (SK-HRp2) | 3 | 1 |
| 292 | Treadted with 2-DEOXY-D-GLUCOSE (Glycolysis inhibitor) | 16 | 3 |
| 293 | Treadted withOXAMATE (Glycolysis inhibitor) | 16 | 3 |
| 294 | Treated MCF7Ca with Letrozole for 56 week | 11 | 1 |
| 295 | Treated MCF7Ca with letrozole for 56 week | 12 | 1 |
| 296 | Treated with 17-AAG ( degrade HER2 protein ) | 2 | 1 |
| 297 | Treated with 17β-ESTRADIOL(E2) | 2 | 1 |
| 298 | Treated with ABT-37 (Bcl-2 inhibitor) | 6 | 2 |
| 299 | Treated with ABT-37 (Bcl-2 inhibitor), BT474 modified to clone BT474-c3 | 2 | 1 |
| 300 | Treated with ABT-37 (Bcl-2 inhibitor), BT474 modified to resistant clone BT474-HRc1 | 2 | 1 |
| 301 | Treated with CBZ ( HDAC6 inhibitor ) | 3 | 1 |
| 302 | Treated with CBZ ( HDAC6 inhibitor ) with Treated with 17-AAG ( degrade HER2 protein ) | 1 | 1 |
| 303 | Treated with Curcumin to inhibit signal transduction pathway(PI3K/AKT, MAPK, NF-KB) | 15 | 1 |
| 304 | Treated with EVEROLIMUS (Mtor inhibitor) | 5 | 1 |
| 305 | Treated with EVEROLIMUS (Mtor inhibitor), BT474 modified to clone BT474 SC | 7 | 1 |
| 306 | Treated with IGF-IR Inhibitor (NVP-AEW541) | 20 | 3 |
| 307 | Treated with LY294002 (PI3K inhibitor ), BT474 modified to resistant clone BT474-HRc1 | 2 | 1 |
| 308 | Treated with LY294002(Inhibitor of PI3K) | 2 | 1 |
| 309 | Treated with NVP-AEW541( IGF1R INHIBITOR ) | 8 | 2 |
| 310 | Treated with NVP-AEW541( IGF1R INHIBITOR ), BT474 modified to resistant clone BT474 /TR | 2 | 1 |
| 311 | Treated with NaB (HISTONE DEACETYLASE inhibitor ) | 4 | 2 |
| 312 | Treated with PBMC mononuclear cells ratio to target cells (80:1) | 9 | 3 |
| 313 | Treated with PPAR GAAMMA inhibitor TGZ (TROGLITAZONE) | 4 | 1 |
| 314 | Treated with PPAR GAAMMA inhibitor TGZ (TROGLITAZONE), MCF7 modified to clone MCF7/HER2 | 2 | 1 |
| 315 | Treated with SF1126 (PI3K INHIBITOR), BT474 modified to resistant clone BT474-HRp2 | 4 | 1 |
| 316 | Treated with SF1126 (PI3K INHIBITOR), BT474 modified to resistant clone BT474-HRp3 | 4 | 1 |
| 317 | Treated with SF1126 (PI3K INHIBITOR), SKBR3 modified to resistant clone SKBR3-HRp2 | 10 | 1 |
| 318 | Treated with SF1126 (PI3K INHIBITOR), SKBR3 modified to resistant clone SKBR3-HRp3 | 10 | 1 |
| 319 | Treated with erythropoitin( EPO) | 6 | 3 |
| 320 | Treated withPD98059(Inhibitor of MEK) | 2 | 1 |
| 321 | Treated withWEDELOLACTONE (IKK inhibitor ), BT474 modified to resistant clone BT474-HRc1 | 2 | 1 |
| 322 | Treatment with heregulin HRGβ1 (10 ng/ml) | 2 | 1 |
| 323 | UACC839 treated with LY294002 ( PI3K inhibitor) | 1 | 1 |
| 324 | WILD TYPE | 2 | 1 |
| 325 | Wild type | 3 | 1 |
| 326 | control, BT474 modified to clone BT474/AA9 | 2 | 1 |
| 327 | control, BT474 modified to clone BT474/DN5 | 2 | 1 |
| 328 | control, MCF7 modified to HER-2 overexpress clone MCF7-HER2 | 2 | 1 |
| 329 | erbB-2 tranfected MCF7/erbB2 | 3 | 1 |
| 330 | knockdown siRNA FOXO1A, BT474 modified to clone BT474/DN5 | 2 | 1 |
| 331 | knockdown siRNA FOXO1A, MCF7 modified to HER-2 overexpress clone MCF7-HER2 | 2 | 1 |
| 332 | knockdown siRNA NEGATIVE CONTROL | 4 | 2 |
| 333 | knockdown siRNA NEGATIVE CONTROL, BT474 modified to clone BT474/DN5 | 2 | 1 |
| 334 | knockdown siRNA NEGATIVE CONTROL, MCF7 modified to HER-2 overexpress clone MCF7-HER2 | 1 | 1 |
| 335 | low express cyclinE | 1 | 1 |
| 336 | β1-Integrin vector transfected in MCF-7/HER-2/β1 | 2 | 1 |
| 337 | β1-Integrin vector transfected in SKBR3/β1-C1 | 12 | 1 |
